BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9369528)

  • 1. TGF-beta receptor type II and fetuin in the developing sheep neocortex.
    Dziegielewska KM; Williams RT; Knott GW; Kitchener PD; Monk SE; Potter A; Saunders NR
    Cell Tissue Res; 1997 Dec; 290(3):515-24. PubMed ID: 9369528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin and fate of fetuin-containing neurons in the developing neocortex of the fetal sheep.
    Saunders NR; Habgood MD; Ward RA; Reynolds ML
    Anat Embryol (Berl); 1992 Oct; 186(5):477-86. PubMed ID: 1280010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute-phase cytokines IL-1beta and TNF-alpha in brain development.
    Dziegielewska KM; Møller JE; Potter AM; Ek J; Lane MA; Saunders NR
    Cell Tissue Res; 2000 Mar; 299(3):335-45. PubMed ID: 10772248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of plasma proteins in the neocortex and early allocortex of the developing sheep brain.
    Reynolds ML; Møllgård K
    Anat Embryol (Berl); 1985; 171(1):41-60. PubMed ID: 3985357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of the foetal protein fetuin by early developing neurons in the immature neocortex.
    Dziegielewska KM; Reader M; Matthews N; Brown WM; Møllgård K; Saunders NR
    J Neurocytol; 1993 Apr; 22(4):266-72. PubMed ID: 7683041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and distribution of fetuin in the developing sheep fetus.
    Saunders NR; Sheardown SA; Deal A; Møllgård K; Reader M; Dziegielewska KM
    Histochemistry; 1994 Dec; 102(6):457-75. PubMed ID: 7535298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetuin in the developing neocortex of the rat: distribution and origin.
    Dziegielewska KM; Daikuhara Y; Ohnishi T; Waite MP; Ek J; Habgood MD; Lane MA; Potter A; Saunders NR
    J Comp Neurol; 2000 Jul; 423(3):373-88. PubMed ID: 10870079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spatiotemporal expression of TGF-beta1 and its receptors during periosteal chondrogenesis in vitro.
    Mizuta H; Sanyal A; Fukumoto T; Fitzsimmons JS; Matsui N; Bolander ME; Oursler MJ; O'Driscoll SW
    J Orthop Res; 2002 May; 20(3):562-74. PubMed ID: 12038632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist.
    Demetriou M; Binkert C; Sukhu B; Tenenbaum HC; Dennis JW
    J Biol Chem; 1996 May; 271(22):12755-61. PubMed ID: 8662721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-beta1 in Aplysia: role in long-term changes in the excitability of sensory neurons and distribution of TbetaR-II-like immunoreactivity.
    Chin J; Angers A; Cleary LJ; Eskin A; Byrne JH
    Learn Mem; 1999; 6(3):317-30. PubMed ID: 10492013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminic acid specific lectins as markers of early cortical plate neurons.
    Adam E; Dziegielewska KM; Saunders NR; Schumacher U
    Int J Dev Neurosci; 1993 Aug; 11(4):451-60. PubMed ID: 7694444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential immunocytochemical staining for fetuin and transferrin in the developing cortical plate.
    Møllgård K; Reynolds ML; Jacobsen M; Dziegielewska KM; Saunders NR
    J Neurocytol; 1984 Aug; 13(4):497-502. PubMed ID: 6207273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
    Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
    Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetuin as a marker of cortical plate cells in the fetal cow neocortex: a comparison of the distribution of fetuin, alpha 2HS-glycoprotein, alpha-fetoprotein and albumin during early development.
    Reynolds ML; Sarantis ME; Lorscheider FL; Saunders NR
    Anat Embryol (Berl); 1987; 175(3):355-63. PubMed ID: 2435194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma.
    Bristow RE; Baldwin RL; Yamada SD; Korc M; Karlan BY
    Cancer; 1999 Feb; 85(3):658-68. PubMed ID: 10091739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TGF-beta type III receptor is localized to the medial edge epithelium during palatal fusion.
    Cui XM; Shuler CF
    Int J Dev Biol; 2000 Jun; 44(4):397-402. PubMed ID: 10949049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DMSO Enhances TGF-β Activity by Recruiting the Type II TGF-β Receptor From Intracellular Vesicles to the Plasma Membrane.
    Huang SS; Chen CL; Huang FW; Hou WH; Huang JS
    J Cell Biochem; 2016 Jul; 117(7):1568-79. PubMed ID: 26587792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma and TNF-alpha inhibit expression of TGF-beta-1, its receptors TBETAR-I and TBETAR-II in the corpus luteum of PMSG/hCG treated rhesus monkey.
    Gao H; Chen XL; Zhang ZH; Song XX; Hu ZY; Liu YX
    Front Biosci; 2005 Sep; 10():2496-503. PubMed ID: 15970512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion.
    Galliher AJ; Schiemann WP
    Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated expression of transforming growth factor beta and its type-I and type-II receptors in basal-cell carcinoma.
    Furue M; Kato M; Nakamura K; Nashiro K; Kikuchi K; Okochi H; Miyazono K; Tamaki K
    Int J Cancer; 1997 May; 71(4):505-9. PubMed ID: 9178800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.